Alector, Inc. (ALEC)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.21
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.09
P/B Ratio
23.54
Institutional Ownership
77.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 10.00M | $20.0M | 8.96% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.85M | $15.0M | 7.03% | +106.6K | 2026-06-30 |
| Nantahala Capital Management, LLC | 4.32M | $8.0M | 3.87% | +1.50M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.01M | $8.0M | 3.59% | +330.6K | 2026-06-30 |
| Kynam Capital Management, LP | 3.81M | $7.0M | 3.41% | +1.81M | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.75M | $7.0M | 3.36% | +816.1K | 2026-06-30 |
| Merck & Co., Inc. | 3.55M | $7.0M | 3.18% | -- | 2026-06-30 |
| 683 Capital Management, LLC | 3.20M | $6.0M | 2.87% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 2.96M | $5.0M | 2.65% | -372.9K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 2.88M | $5.0M | 2.58% | +1.83M | 2026-06-30 |